Israel Englander’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Israel Englander's CLBT Position: Q2 2026 in Review
Israel Englander sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 232,027 shares — an estimated $3.2M sold.
Israel Englander first reported a position in CLBT in Q3 2022 and held it in 14 quarters. The position peaked at $32M in Q2 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Israel Englander reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
- Israel Englander sold 232,027 Cellebrite shares in Q2 2026, an estimated $3.2M.
- Israel Englander first reported a position in Cellebrite in Q3 2022 and held it in 14 quarters.
- Israel Englander's Cellebrite position peaked at $32M in Q2 2025.
- 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.